Omnicell recently reported Q4 2025 results that exceeded its own guidance across revenue, product bookings, and annual recurring revenue, while launching the Titan XT system to extend intelligent ...

Feb 24 (Reuters) - Taser-maker Axon Enterprise beat Wall Street estimates for fourth-quarter profit on Tuesday, driven by strong demand for its security devices and software products. Shares of the ...

PM EST One nuance: cash flow margin was still excellent, but FCF margin fell from 42% to 33% YoY, which may also be weighing ...

Emerson Electric (EMR) shares are back in focus after the company reported year-over-year earnings growth and positive ...

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript March 5, 2026 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.51, expectations were $0.23. Operator: Good ...

Earlier this week, Revvity reported stronger-than-expected Q4 2025 results, with Diagnostics delivering 10% reported revenue ...

(NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed ...

Flat in Q4, with management targeting a range of 1%-2% for the coming year, following a trajectory from -2% three years ago, ...

Guidance for organic growth was revised from a 3% target for 2026 in the previous quarter to a 1%-2% target in the current quarter, indicating a more conservative outlook.

These are the ASX growth shares I would back for a decade. The post 3 ASX growth shares I'd back to beat the market over the next decade appeared first on The Motley Fool Australia.

Upland Software, Inc. (NASDAQ:UPLD) Q4 2025 Earnings Call Transcript March 3, 2026 Upland Software, Inc. misses on earnings ...